Literature DB >> 25789537

Pseudosarcomatous Spindle Cell Proliferation With Osteoid Matrix Mimicking Osteosarcoma: A Distinct Histologic Phenotype in Giant Cell Tumor of Bone Following Denosumab Therapy.

Neetha Santosh1, Joel L Mayerson, Obiajulu H Iwenofu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 25789537     DOI： 10.1097/PAI.0000000000000165

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN： 1533-4058


× No keyword cloud information.
  4 in total

Review 1.  Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence.

Authors:  Aneta Maria Borkowska; Anna Szumera-Ciećkiewicz; Bartłomiej Szostakowski; Andrzej Pieńkowski; Piotr Lukasz Rutkowski
Journal:  Cancers (Basel)       Date:  2022-05-04       Impact factor: 6.575

2.  Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab.

Authors:  Emanuela Palmerini; Leanne L Seeger; Marco Gambarotti; Alberto Righi; Peter Reichardt; Susan Bukata; Jean-Yves Blay; Tian Dai; Danielle Jandial; Piero Picci
Journal:  BMC Cancer       Date:  2021-01-22       Impact factor: 4.430

3.  Comprehensive treatment outcomes of giant cell tumor of the spine: A retrospective study.

Authors:  Kazuhiko Hashimoto; Shunji Nishimura; Hiroshi Miyamoto; Kensuke Toriumi; Terumasa Ikeda; Masao Akagi
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

4.  Two Cases of Sarcoma Arising in Giant Cell Tumor of Bone Treated with Denosumab.

Authors:  Cory Julian Broehm; Erika L Garbrecht; Jeff Wood; Therese Bocklage
Journal:  Case Rep Med       Date:  2015-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.